CNN sits down with Ester Baiget, CEO of Novonesis, to discuss how biotechnology can boost food production in the Gulf.

A promising biotechnology company developed a new approach that might treat a rare disease — but its sole employee didn’t do ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Vir Biotechnology Inc (NASDAQ:VIR) shares fell 15% in premarket trade Friday following the company's announcement of a $150 million public stock offering priced at $10 per share.

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious ...

Recent advancements in biotechnology have immense potential to help address many global problems; climate change, an aging society, food security, energy security, and infectious diseases.

Vir Biotechnology remains a Buy after flawless Phase 3 ECLIPSE 1 results and a major new Gilead partnership. Read more on VIR ...

Sana Biotechnology, Inc. reported third-quarter 2026 financial results and business updates, highlighting progress toward clinical studies of its engineered cell therapy programs ...

What happened? Shares of Vir Biotechnology fell 18.8% in the afternoon session after the company announced, in a company press release, the pricing of an underwritten public offering of 15 million ...